Cannabis Investing Forum – Elixinol Global 031821

www.cannabisinvestingforum.com

Oliver Horn was most recently CEO of Swisse Wellness for Australia and New Zealand (ANZ) and North America. Oliver has previously held senior operational leadership positions at Treasury Wine Estates across ANZ, Europe, Middle East and Africa.
With an established track record for exponential growth in established and emerging markets, Oliver has extensive experience in building premium global consumer brands, a deep knowledge of the vitamins, minerals and supplements (VMS) category, a track record of premium brand building and a passion for creating businesses with a positive and thriving workplace culture.
Prior to Elixinol Oliver was CEO of Swisse Wellness For Australia and New Zealand (ANZ) and North America and has previously held senior operational leadership positions at Treasury Wine Estates across ANZ, Europe, Middle East and Africa. With an established track record for exponential growth in both established and emerging markets, Oliver has extensive experience in building premium global consumer brands, a deep knowledge of the vitamins, minerals and supplements (VMS) category, a track record of premium brand building and a passion for creating businesses with a positive and thriving workplace culture.
About Elixinol Global Limited
Elixinol is an original pioneer in the CBD industry — focused on the science, research and development of world-class cannabinoid products that provide real results for real people. A global company with a proven track record, Elixinol’s products are sold online at Elixinol.com, at over 2,600 natural, specialty and conventional grocery stores and pharmacies across the U.S., and around the world. Elixinol distributes CBD products in North and South America, throughout Europe, Asia and the Pacific Region under the Elixinol brand. Elixinol’s parent company EXL (elixinolglobal.com) is publicly traded on the Australian Securities Exchange (EXL) and on OTC Markets (ELLXF).

Posted in Investors